Will United Therapeutics Corporation (UTHR) Beat the Rest of the Stocks in the Healthcare Sector?

Monday, May 23, 2022 12:00 PM | InvestorsObserver Analysts

Mentioned in this article

Will United Therapeutics Corporation (UTHR) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 83 puts United Therapeutics Corporation (UTHR) near the top of the Healthcare sector according to InvestorsObserver. United Therapeutics Corporation's score of 83 means that it ranks higher than 83% of stocks in the sector. In addition, its overall score of 84 ranks it higher than 84% of all stocks.

UTHR has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on UTHR!

See Full UTHR Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With United Therapeutics Corporation Stock Today?

United Therapeutics Corporation (UTHR) stock is trading at $192.70 as of 11:43 AM on Monday, May 23, a gain of $4.37, or 2.32% from the previous closing price of $188.33. The stock has traded between $188.81 and $193.83 so far today. Volume today is below average. So far 162,949 shares have traded compared to average volume of 399,249 shares. Click Here to get the full Stock Report for United Therapeutics Corporation stock.